ir.tiongaik.com.sg
Overview | Investor Relations | Tiong Aik
Call us: 65 6392 2988. We are an established quality property and construction group with a track record of almost 40 years’ experience in the Singapore construction industry and over 15 years’ experience in real estate development. Feb 28, 2018. Dec 12, 2017. Award of main contract worth S$180 million by JTC Corporation for a building development project. View all news releases ». No1 Jalan Berseh #03-03. New World Centre Singapore 209037. Tel : 65 6392 2988. Fax: 65 6392 0988.
ir.tiptopjob.com
Jobs in Iran : IT Sales Accountancy Financial Graduate Teaching Catering Engineering Manufacturing Marketing Secretarial Charity Advertising Transport Construction - Job Search Engine for Recruitment Employment Vacancy Career Advice Jobs By Email
Upload CV / Resume. It's quick, easy and free. Let recruiters find you. Get jobs in your mailbox. Search for Jobs in Iran. This is the Iran Tip Top Job site. An online recruitment service for jobseekers to search jobs. And recruiters to advertise job vacancies. In Iran and worldwide. Search and find a job today! Job search - find jobs in Iran with Tip Top Job. If you want to carry out a quick or extensive job search, Tip Top Job can help you. We have thousands of vacancies in Iran and across the world.
ir.titan.gr
TITAN - Investor Relations Portal
Παρασκευή, 30 Μαρτίου 2018. TITK [29/03/2018 17:10] 20.15 (-1.23%). Bid[20.15] Ask[19.60] Volume[0] High[20.55] Low[20.15]. TITP [29/03/2018 17:12] 16.50 (-1.20%). Bid[16.50] Ask[16.50] Volume[0] High[17.00] Low[16.50]. Ανακοίνωση Αποτελεσμάτων Έτους 2017. Ολοκλήρωση διάθεσης ομολογιών συνολικής ονομαστικής αξίας 250 εκ. Ευρώ από την TITAN GLOBAL FINANCE PLC. Αναγγελία πρόθεσης έκδοσης νέων εγγυημένων ομολογιών ποσού 250.000.000 από την TITAN GLOBAL FINANCE PLC. Ανακοίνωση Αποτελεσμάτων 9M 2017.
ir.titanmachinery.com
Investor Relations
Annual Meeting of Stockholders. June 4, 2015 at 8:00 AM CT. Held at the offices of: Fredrikson and Byron. 200 South 6th Street, Suite 4000 - Minneapolis, Minnesota. Primary IR Contact: John Mills, Senior Managing Director john.mills@icrinc.com. Phone: (310) 954-1100 Fax: (310) 954-1101. Sign Up for Investor Relations Alerts. NH - Build and Price - NEW. CIH - Build and Price - NEW. Free Titan Trader Magazine – online or delivered to your home or business.
ir.tkg.jp
株主・投資家情報 | 東京個別指導学院
8/17本日発売 週刊エコノミスト に当社社長 齋藤勝己の記事が掲載されました. Benesse サイエンス教室 ４ ５歳児対象 年中生コース の開講月前倒しに関するお知らせ. ファクトブック / 有価証券報告書 / 事業報告書.
ir.tmk-group.com
INVESTORS
MOEX (RUR): 56.30. Change in % 0.72. Change in % -2.54. Credit ratings and risks. News and IR calendar. TMK Photo Gallery on Flickr. TMK at a glance. TMK Middle East Division. Oil country tubular goods (OCTG). Welded large diameter pipe. Middle East, Asia and Africa. TMK Italia s.r.l. Credit ratings and risks. News and IR calendar. TMK video for investors. TMK securities are traded on the London Stock Exchange, the OTCQX trading platform and Moscow Exchange. Change of the commercial name of TMK. TMK Midd...
ir.tncommercebank.com
T.N. Commerce Bank - Bank on Us!
Bank on the TN Commerce Site Updates. May 14, 2015. Once you’ve browsed and shopped on the TN Commerce Bank site, you’ll discover why you’ll want to return again and again! Money and Finance are areas where just about everyone is looking to do better with these days, and for good reason. The economy is tight we get that! Bank on the TN Commerce Site Updates. Proudly powered by WordPress. By Michael Van Den Berg.
ir.toba.co.jp
株式会社鳥羽洋行｜株主・投資家の皆様へ
株式基本情報、株主還元 配当等 、株主優待情報、株主の状況 等.
ir.tobiratherapeutics.com
Investor Relations - Tobira Therapeutics
Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies targeting serious diseases of immune-inflammation and fibrosis. The company’s lead product candidate, cenicriviroc (CVC), is a first-in-class immunomodulator and dual inhibitor of CCR2 and CCR5. CVC is being evaluated for the treatment of non-alcoholic steatohepatitis (NASH) and has received FastTrack Designation from the FDA. August 17, 2015. August 11, 2015. View all press releases ».
ir.tobiratx.com
Investor Relations - Tobira Therapeutics
Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies targeting serious diseases of immune-inflammation and fibrosis. The company’s lead product candidate, cenicriviroc (CVC), is a first-in-class immunomodulator and dual inhibitor of CCR2 and CCR5. CVC is being evaluated for the treatment of non-alcoholic steatohepatitis (NASH) and has received FastTrack Designation from the FDA. Oct 20, 2016. Oct 19, 2016. Sep 21, 2016 at 2:30 PM PT.
SOCIAL ENGAGEMENT